Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2012
12/19/2012CN102824389A Sugar-free panax notoginseng saponin medicine composition with low moisture absorption, good processability and easy absorption, preparation method and application
12/19/2012CN102824383A Method for extracting madagascar periwinkle herb total alkaloid
12/19/2012CN102824376A Cordyceps sinensis powder and preparation method and application thereof
12/19/2012CN102824368A Pearl vitamin C tablet and preparation method thereof
12/19/2012CN102824358A Policresulen compound suppository and preparation method
12/19/2012CN102824357A Polysaccharide sulphate pharmaceutical compound for injection
12/19/2012CN102824343A Solid pharmaceutical composition containing benzimidazole derivative
12/19/2012CN102824339A Application of sodium butyrate in preparation of hypoxic pulmonary hypertension control medicines
12/19/2012CN102824336A Application of (E)-2-(3,5-dimethoxybenzylidene)-cyclopentanone in preparing medicine for treating cerebrovascular diseases
12/19/2012CN102824325A Quercetin sustained release tablet and preparing method thereof
12/19/2012CN102823866A Dietetic therapy product of sea-buckthorn lotus leaf juice for conditioning blood fat, reducing blood viscosity and improving myocardial blood
12/19/2012CN102823792A Soft propolis astragalus mongholicus capsule and preparation method thereof
12/19/2012CN102823405A Ginseng for treating high blood pressure and culture process of ginseng
12/19/2012CN102429858B Preparation method and application of sustained-release BIO/IGF (6-bromoindirubin-3'-oxime/insulin-like growth factor) composite hydrogel
12/19/2012CN102379892B Blood lipid regulation, antiatherosclerotic and anti-myocardial ischemia functions of clematichinenoside
12/19/2012CN102178678B Application of lycorine in preparing medicament for treating diseases caused by human enterovirus 71 type infection
12/19/2012CN102138901B Nasal spray or aerosol containing Fasudil
12/19/2012CN102115787B MicroRNA (Ribose Nucleic Acid) and application of antisensenucleic acid of microRNA in diagnosis, prevention, treatment and/or prognostic evaluation of heart disease
12/19/2012CN102091045B Hydrochloride diltiazem composition for injection and preparation method thereof
12/19/2012CN102058786B Chinese medicine composition for treating hypertension and preparation method thereof
12/19/2012CN102008471B Lacidipine self-microemulsifying soft capsules and preparation method thereof
12/19/2012CN101991533B Puerarin liposome microsphere injection and preparation method thereof
12/19/2012CN101983637B Radix trichosanthis saponin and application of radix trichosanthis saponin in preparing medicine for treating ischemic cerebrovascular diseases
12/19/2012CN101926788B Cardiovascular/cerebral and ophthalmological medicines, and preparation and use thereof
12/19/2012CN101863879B Preparation method of alpha crystalline azelnidipine
12/19/2012CN101584853B 一种地龙蛋白多肽制剂 An earth dragon polypeptide formulations
12/19/2012CN101454320B Pyridine[3,4-b]pyrazinones
12/19/2012CN101336705B Health food and its preparation method
12/19/2012CN101301475B Peg化因子vii糖型 Peg factor vii sugar type
12/19/2012CN101068794B Quinazolines useful as modulators of ion channels
12/18/2012US8334321 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
12/18/2012US8334259 Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative
12/18/2012US8333958 HSA-free formulations of interferon-Beta
12/18/2012CA2754102C Monoclonal antibodies and compositions comprising such useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/18/2012CA2719721C Tetrahydroisoquinoline derivative
12/18/2012CA2621867C Adhesive pharmaceutical preparation containing bisoprolol
12/18/2012CA2525502C Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
12/18/2012CA2407895C Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
12/13/2012WO2012169897A1 Weight reducing material
12/13/2012WO2012169863A2 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof
12/13/2012WO2012169654A1 Carbon-monoxide(co)-assisted inhibition of fatty acid and cholesterol uptake
12/13/2012WO2012168852A1 Cysteine protease inhibitors
12/13/2012WO2012168450A1 Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions
12/13/2012WO2012167617A1 β INHIBITING PROTEIN 1, FRAGMENTS THEREOF, AND USE THEREOF
12/13/2012WO2012145234A3 Cyclopropyl derivatives and methods of use
12/13/2012WO2012131412A3 Pharmaceutical composition containing no, process for the preparation and use thereof
12/13/2012WO2012117075A3 Treatment of cerebral ischemia
12/13/2012WO2012115439A3 Composition comprising expression or activity regulators of akap12 for treating central nerve system diseases
12/13/2012WO2012065059A3 Treatment of atherosclerosis with bmp-alk3 antagonists
12/13/2012US20120316380 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316249 Lycopene for the treatment for metabolic dysfunction
12/13/2012US20120316246 Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
12/13/2012US20120316245 Co-crystals of agomelatine, a process for there preparation and pharmaceutical compositions containing them
12/13/2012US20120316219 Modulation of apolipoprotein(a) expression
12/13/2012US20120316216 Pyrrolidine substitute flavones for the treatment of inflammatory disorders
12/13/2012US20120316212 Amino alcohol derivatives and their therapeutic activities
12/13/2012US20120316211 Diagnostic Methods for Assessing Risk of Chagas Disease and Heart Failure
12/13/2012US20120316198 Hydrazone and diacyl hydrazine compounds and methods of use
12/13/2012US20120316195 Aryl-pyridine derivatives as aldosterone synthase inhibitors
12/13/2012US20120316194 Apoptosis signal-regulating kinase 1 inhibitors
12/13/2012US20120316186 Deazapurines useful as inhibitors of janus kinases
12/13/2012US20120316183 Novel solvates of methylcarbamate
12/13/2012US20120316173 Compounds which modulate the cb2 receptor
12/13/2012US20120316172 Pyrazole derivatives
12/13/2012US20120316169 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
12/13/2012US20120316166 Hetarylaminonaphthyridines
12/13/2012US20120316165 Substituted benzamide derivatives
12/13/2012US20120316163 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316159 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
12/13/2012US20120316156 [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid
12/13/2012US20120316152 Substituted isoquinolineand isoquinolinone derivatives
12/13/2012US20120316147 Novel pyridine derivatives
12/13/2012US20120316139 Anti-inflammatory compounds and uses thereof
12/13/2012US20120316132 Pharmaceutical oral dosage form containing a synthetic oligosaccharide
12/13/2012US20120316128 Citicoline for the treatment of glaucoma and ocular hypertension
12/13/2012US20120316122 Pharmaceutical compositions for combating thrombotic diseases and their preparation and uses
12/13/2012US20120316121 Materials and Methods for Modulating Arginine Metabolism
12/13/2012US20120316110 Injectable Cross-Linked Polymeric Preparations and Uses Thereof
12/13/2012US20120316101 Peptides for targeting apoptotic cells and uses thereof
12/13/2012US20120316100 Therapeutic Use of Peptide Inhibitors of NADPH Oxidase; Aerosolization as a Delivery Mechanism
12/13/2012US20120315328 Capsule of compound danshen dripping pills
12/13/2012US20120315326 Multiparticulate l-carnitine compositions and related methods
12/13/2012US20120315303 Methods and intravascular treatment devices using paclitaxel for treatment of atherosclerosis
12/13/2012US20120315288 LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY
12/13/2012US20120315285 Antibody Formulation
12/13/2012US20120315283 Methods of promoting tissue growth and tissue regeneration
12/13/2012US20120315282 Antibodies Specific for TGF-Beta
12/13/2012US20120315279 Compositions and method of modulating growth factor function
12/13/2012US20120315267 Novel uses
12/13/2012US20120315266 Detecting complement activation
12/13/2012US20120315257 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
12/13/2012US20120315247 Compounds comprising a spiro-ring and methods of use
12/13/2012CA2836728A1 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof
12/12/2012EP2532658A1 Therapeutic agent for cerebral infarction
12/12/2012EP2532390A2 Pharmaceutical composition for obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
12/12/2012EP2532389A2 Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
12/12/2012EP2532388A2 Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
12/12/2012EP2532357A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
12/12/2012EP2531509A1 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
12/12/2012EP2531222A1 Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 1595